MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Oligosymptomatic Fahr’s syndrome (2 clinical cases)

    Y. Solodovnikova (Odessa, Ukraine)

    Objective: Two clinical cases of Fahr`s syndrome was presented. Background: Fahr's syndrome (FS) or secondary bilateral striatopallidodentate calcinosis is a rare neurological disorder characterized by…
  • 2018 International Congress

    Cerebrotendinous Xanthomatosis: A heterogeneous condition

    D. Cerdán, B. Fernández, J. Eguizábal, P. Gil, A. Mendoza, A. Castrillo, F. Rodríguez, C. Tabernero, J. Duarte (Segovia, Spain)

    Objective: Cerebrotendinous xanthomatosis(CTX)is a relentless progressive disorder with treatment predominantly preventive,so early diagnosis is crucial.The object of this study is to evaluate clinical manifestations and…
  • 2018 International Congress

    Clinical characterization of tremor in patients with Phenylketonuria (PKU)

    F. Nardecchia, F. Manti, S. De Leo, C. Carducci, V. Leuzzi (Rome, Italy)

    Objective: To assess the occurrence, age at onset, distribution, associated neurological signs and possible pathogenetic biomarkers of tremor in PKU. Background: PKU is an inborn…
  • 2018 International Congress

    Neurological improvement with WTX101 treatment in a Phase 2, multi-center, open label study in Wilson Disease

    D. Bega, J. Bronstein, D. Nicholl, F. Askari, A. Ala, P. Ferenci, C. Bjartmar, KH. Weiss, M. Schilsky, A. Czlonkowska (Chicago, IL, USA)

    Objective: The objective of this study was to characterize neurological manifestations in Wilson Disease (WD) patients and describe specific neurological changes after 24 weeks’ treatment…
  • 2018 International Congress

    Neurologic Wilson’s Disease: Case Series on a Diagnostic and Therapeutic Emergency

    R. Porlas, L. De Castillo, C. Dioquino (Manila, Philippines)

    Objective: To present two cases of Neurologic Wilson's Disease with two different clinical picture. To review the the important diagnostics and tests in clinching the…
  • 2018 International Congress

    The first case of Perry syndrome in Estonia

    K. Vender, T. Toomsoo, I. Kalju, I. Rubanovits, K. Joost, P. Taba (Tallinn, Estonia)

    Objective: Perry syndrome is an autosomal dominant disorder characterized by progressive parkinsonism and central hypoventilation. Background: Since the original publication in 1975 there have been…
  • 2018 International Congress

    An international survey of stiff person spectrum disorders: Exploring the clinical spectrum and unmet needs

    B. Balint, E. Gatto, J. Etcheverry, M. Cesarini, V. Virginia Parisi, M. Rodriguez Violante, P. Garcia Ruiz, K. Bhatia (London, United Kingdom)

    Objective: To build a platform in order to investigate the clinical spectrum of stiff person syndrome and related disorders, and to explore possible gaps in…
  • 2018 International Congress

    Biological course and natural history of hereditary spastic paraplegia type 11 (SPG11)

    T. Musacchio, K. Nohl, K. Boelmans, V. Maltese, D. Zeller, I. Isaias, J. Volkmann, S. Klebe (Würzburg, Germany)

    Objective: We aim to establish biological markers for the natural history and course of hereditary spastic paraplegia (HSP) type 11 (SPG11) using multiple readout parameters…
  • 2018 International Congress

    Explosive flurry of seizures and new-onset cortical-subcortical lesions in a patient with Wilson disease

    A. Aggarwal, M. Munshi, P. Gadgil, D. Sanghvi, M. Bhatt (Mumbai, India)

    Objective: We report a patient with stable neurological Wilson disease (WD) who developed repeated seizures and new-onset cortical-subcortical lesions, and discuss the possible causes for…
  • 2018 International Congress

    Dystonia ataxia (DYTCA) syndrome with prominent handwriting deterioration associated with ADCK3 mutation: two new cases and an overview of the literature

    S. Galosi, T. Schirinzi, E. Bertini, R. Haas, F.M. Santorelli, V. Leuzzi, J.R. Friedman (Rome, Italy)

    Objective: To report two new patients with ADCK3 mutation presenting with writing deterioration as first sign of DYTCA syndrome. To provide an overview of clinical…
  • « Previous Page
  • 1
  • …
  • 1240
  • 1241
  • 1242
  • 1243
  • 1244
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley